Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
Phase 2a clinical trials demonstrate benfotiamine’s ability to enhance synaptic activity while maintaining an excellent safety profile, even at doses exceeding normal thiamine blood levels.
Family Medicine/General Practice December 4th 2024
Epoch Health
23 million Americans take levothyroxine daily, making it one of the nation’s most prescribed medications, with new evidence suggesting potential risks to bone health even at standard therapeutic levels.
Endocrinology, Diabetes, Metabolism December 4th 2024
Medical News Today (MNT)
For sedentary individuals, matching the activity levels of the most physically active population segment (160 minutes of daily walking at 3 mph) could extend life expectancy by up to 11 years.
Cardiology December 3rd 2024
Conexiant
Of 37 clinical questions examined by international experts, only 6 received clear evidence-based recommendations, highlighting significant gaps in UTI management evidence.
Family Medicine/General Practice November 27th 2024
SingleCare
Clinical evidence shows that as people age, their bodies become less efficient at clearing cholesterol from the bloodstream, necessitating more aggressive monitoring and management strategies.
Cardiology November 27th 2024
Journal of the American College of Cardiology (JACC)
A landmark analysis shows that physiology-guided complete revascularization reduced adverse outcomes by approximately 25% compared to culprit-only strategy across both STEMI and NSTEMI patients.
Cardiology November 25th 2024